Antitumoral Activity of Lenalidomide in in Vitro and in Vivo Models of Mantle Cell Lymphoma Involves the Destabilization of Cyclin D1/p27KIP1 Complexes.

Moros A; Bustany S; Cahu J; Saborit-Villarroya I; Martínez A; Colomer D; Brigitte Sola; Roué G

doi:10.1158/1078-0432.ccr-13-1569

Journal articles

Antitumoral Activity of Lenalidomide in in Vitro and in Vivo Models of Mantle Cell Lymphoma Involves the Destabilization of Cyclin D1/p27KIP1 Complexes.

Moros A Bustany S Cahu J Saborit-Villarroya I Martínez A Colomer D Brigitte Sola ¹ Roué G

1 MILPAT - Microenvironnement cellulaire et pathologie

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Complete list of metadata

https://hal-normandie-univ.archives-ouvertes.fr/hal-01762008
Contributor : Université Normandie Connect in order to contact the contributor
Submitted on : Monday, April 9, 2018 - 3:50:07 PM
Last modification on : Wednesday, January 5, 2022 - 2:10:23 PM

Antitumoral Activity of Lenalidomide in in Vitro and in Vivo Models of Mantle Cell Lymphoma Involves the Destabilization of Cyclin D1/p27KIP1 Complexes.

Identifiers

Collections

Citation

Export

Metrics

11

Antitumoral Activity of Lenalidomide in in Vitro and in Vivo Models of Mantle Cell Lymphoma Involves the Destabilization of Cyclin D1/p27KIP1 Complexes.

Identifiers

Collections

Citation

Export

Share

Metrics

11